High Capacity podcast

What Explains China's Biotech Rise? Genomics, Data, and the Global Biotech Ecosystem

0:00
1:02:22
Rewind 15 seconds
Fast Forward 15 seconds

Why is China’s biotech industry advancing so quickly? I talk with Abigail Coplin of Vassar College to unpack China’s biotech strategy, BGI, genomics, AI-driven drug discovery, gene therapies, biotech regulation, and what the U.S.-China biotech race means for innovation, national security, and the future of medicine.


  • Why has China emerged so quickly as a global biotech powerhouse?
  • What gives Chinese biotech companies an edge over their Western competitors?
  • How did BGI become one of the world’s most influential genomics companies?
  • Why are China’s gene and cell therapies advancing so rapidly?
  • What should U.S. policymakers know about China's biotech industry?


Links:


For transcripts and more information, check out the High Capacity newsletter.

Follow host Kyle Chan on Twitter / X.

More episodes from "High Capacity"